BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38335183)

  • 1. Peripheral blood mononuclear cell mitochondrial dysfunction in acute alcohol-associated hepatitis.
    Bellar A; Welch N; Dasarathy J; Attaway A; Musich R; Kumar A; Sekar J; Mishra S; Sandlers Y; Streem D; Nagy LE; Dasarathy S
    Clin Transl Med; 2023 May; 13(5):e1276. PubMed ID: 37228227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the complementary information from an increased number of biologically relevant features in liquid biopsy-derived RNA-Seq data.
    Giannoukakos S; D'Ambrosi S; Koppers-Lalic D; Gómez-Martín C; Fernandez A; Hackenberg M
    Heliyon; 2024 Mar; 10(6):e27360. PubMed ID: 38515664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonizing heterogeneous transcriptomics datasets for machine learning-based analysis to identify spaceflown murine liver-specific changes.
    Ilangovan H; Kothiyal P; Hoadley KA; Elgart R; Eley G; Eslami P
    NPJ Microgravity; 2024 Jun; 10(1):61. PubMed ID: 38862523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical review of machine-learning for "multi-omics" marine metabolite datasets.
    Manochkumar J; Cherukuri AK; Kumar RS; Almansour AI; Ramamoorthy S; Efferth T
    Comput Biol Med; 2023 Oct; 165():107425. PubMed ID: 37696182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How (Not) to Generate a Highly Predictive Biomarker Panel Using Machine Learning.
    Desaire H
    J Proteome Res; 2022 Sep; 21(9):2071-2074. PubMed ID: 36004690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning.
    Listopad S; Magnan C; Day LZ; Asghar A; Stolz A; Tayek JA; Liu ZX; Jacobs JM; Morgan TR; Norden-Krichmar TM
    PLOS Digit Health; 2024 Feb; 3(2):e0000447. PubMed ID: 38335183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data.
    Swan AL; Stekel DJ; Hodgman C; Allaway D; Alqahtani MH; Mobasheri A; Bacardit J
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S2. PubMed ID: 25923811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus.
    Li Y; Ma C; Liao S; Qi S; Meng S; Cai W; Dai W; Cao R; Dong X; Krämer BK; Yun C; Hocher B; Hong X; Liu D; Tang D; He J; Yin L; Dai Y
    Front Immunol; 2022; 13():969509. PubMed ID: 36524113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative transcriptomic, proteomic, and machine learning approach to identifying feature genes of atrial fibrillation using atrial samples from patients with valvular heart disease.
    Liu Y; Bai F; Tang Z; Liu N; Liu Q
    BMC Cardiovasc Disord; 2021 Jan; 21(1):52. PubMed ID: 33509101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of follistatin-like protein 1 in liver diseases.
    Gu C; Xue H; Yang X; Nie Y; Qian X
    Exp Biol Med (Maywood); 2023 Feb; 248(3):193-200. PubMed ID: 36533576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples.
    Listopad S; Magnan C; Asghar A; Stolz A; Tayek JA; Liu ZX; Morgan TR; Norden-Krichmar TM
    JHEP Rep; 2022 Oct; 4(10):100560. PubMed ID: 36119721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive proteomic biomarkers for alcohol-related liver disease.
    Niu L; Thiele M; Geyer PE; Rasmussen DN; Webel HE; Santos A; Gupta R; Meier F; Strauss M; Kjaergaard M; Lindvig K; Jacobsen S; Rasmussen S; Hansen T; Krag A; Mann M
    Nat Med; 2022 Jun; 28(6):1277-1287. PubMed ID: 35654907
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.